SIGHT SCIENCES, INC. Increase (Decrease) in Accrued Liabilities
SIGHT SCIENCES, INC. (SGHT) reported Increase (Decrease) in Accrued Liabilities of -$57.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2026-08-05
- SIGHT SCIENCES, INC. increase (decrease) in accrued liabilities for the quarter ending 2026-06-30 was -$5.62M, a 1467.40% decline year-over-year.
- SIGHT SCIENCES, INC. increase (decrease) in accrued liabilities for the quarter ending 2026-03-31 was $5.56M.
- SIGHT SCIENCES, INC. increase (decrease) in accrued liabilities for the quarter ending 2025-12-31 was -$617.00K.
- SIGHT SCIENCES, INC. increase (decrease) in accrued liabilities for the quarter ending 2025-09-30 was -$850.00K.
- SIGHT SCIENCES, INC. increase (decrease) in accrued liabilities for fiscal 2025 was -$1.07M.
- SIGHT SCIENCES, INC. increase (decrease) in accrued liabilities for fiscal 2024 was -$347.00K.
- SIGHT SCIENCES, INC. increase (decrease) in accrued liabilities for fiscal 2023 was -$4.61M, a 274.83% decline from fiscal 2022.
- SIGHT SCIENCES, INC. increase (decrease) in accrued liabilities for fiscal 2022 was $2.63M, a 670.18% increase from fiscal 2021.
| Period end | Increase (Decrease) in Accrued Liabilities 3 month | Increase (Decrease) in Accrued Liabilities 6 month | Increase (Decrease) in Accrued Liabilities 9 month | Increase (Decrease) in Accrued Liabilities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$5.62M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$57.00K 10-Q · filed 2026-08-05 | -$674.00K derived: sum of 3 quarters · filed 2026-08-05 | -$1.52M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $5.56M 10-Q · filed 2026-05-06 | $4.95M derived: sum of 2 quarters · filed 2026-05-06 | $4.10M derived: sum of 3 quarters · filed 2026-05-06 | $4.51M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | -$617.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | -$1.47M derived: sum of 2 quarters · filed 2026-03-04 | -$1.06M derived: sum of 3 quarters · filed 2026-08-05 | -$1.07M 10-K · filed 2026-03-04 |
| 2025-09-30 | -$850.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$439.00K derived: sum of 2 quarters · filed 2026-08-05 | -$458.00K 10-Q · filed 2025-11-06 | -$1.22M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $411.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $392.00K 10-Q · filed 2026-08-05 | -$373.00K derived: sum of 3 quarters · filed 2026-08-05 | -$1.86M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | -$19.00K 10-Q · filed 2026-05-06 | -$784.00K derived: sum of 2 quarters · filed 2026-05-06 | -$2.27M derived: sum of 3 quarters · filed 2026-05-06 | -$2.48M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | -$765.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | -$2.26M derived: sum of 2 quarters · filed 2026-03-04 | -$2.46M derived: sum of 3 quarters · filed 2026-03-04 | -$347.00K 10-K · filed 2026-03-04 |
| 2024-09-30 | -$1.49M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$1.70M derived: sum of 2 quarters · filed 2025-11-06 | $418.00K 10-Q · filed 2025-11-06 | -$1.10M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | -$207.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $1.91M 10-Q · filed 2025-08-07 | $393.00K derived: sum of 3 quarters · filed 2025-08-07 | $198.00K derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | $2.12M 10-Q · filed 2025-05-08 | $600.00K derived: sum of 2 quarters · filed 2025-05-08 | $405.00K derived: sum of 3 quarters · filed 2025-05-08 | -$1.14M derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | -$1.52M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-07 | -$1.71M derived: sum of 2 quarters · filed 2025-03-07 | -$3.26M derived: sum of 3 quarters · filed 2025-03-07 | -$4.61M 10-K · filed 2025-03-07 |
| 2023-09-30 | -$195.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$1.74M derived: sum of 2 quarters · filed 2024-11-07 | -$3.09M 10-Q · filed 2024-11-07 | -$2.09M derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | -$1.55M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-02 | -$2.89M 10-Q · filed 2024-08-02 | -$1.89M derived: sum of 3 quarters · filed 2024-08-02 | -$859.00K derived: sum of 4 quarters · filed 2024-08-02 |
| 2023-03-31 | -$1.34M 10-Q · filed 2024-05-06 | -$342.00K derived: sum of 2 quarters · filed 2024-05-06 | $690.00K derived: sum of 3 quarters · filed 2024-05-06 | $817.00K derived: sum of 4 quarters · filed 2024-05-06 |
| 2022-12-31 | $1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | $2.04M derived: sum of 2 quarters · filed 2024-03-13 | $2.16M derived: sum of 3 quarters · filed 2024-03-13 | $2.63M 10-K · filed 2024-03-13 |
| 2022-09-30 | $1.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $1.16M derived: sum of 2 quarters · filed 2023-11-07 | $1.63M 10-Q · filed 2023-11-07 | $1.76M derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | $127.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | $599.00K 10-Q · filed 2023-08-07 | $730.00K derived: sum of 3 quarters · filed 2023-08-07 | -$653.00K derived: sum of 4 quarters · filed 2023-08-07 |
| 2022-03-31 | $472.00K 10-Q · filed 2023-05-08 | $603.00K derived: sum of 2 quarters · filed 2023-05-08 | -$780.00K derived: sum of 3 quarters · filed 2023-05-08 | -$163.00K derived: sum of 4 quarters · filed 2023-05-08 |
| 2021-12-31 | $131.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | -$1.25M derived: sum of 2 quarters · filed 2023-03-16 | -$635.00K derived: sum of 3 quarters · filed 2023-03-16 | $342.00K 10-K · filed 2023-03-16 |
| 2021-09-30 | -$1.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$766.00K derived: sum of 2 quarters · filed 2022-11-10 | $211.00K 10-Q · filed 2022-11-10 | -$170.00K derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $617.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $1.59M 10-Q · filed 2022-08-11 | $1.21M derived: sum of 3 quarters · filed 2022-08-11 | $1.29M derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $977.00K 10-Q · filed 2022-05-10 | $596.00K derived: sum of 2 quarters · filed 2022-05-10 | $676.00K derived: sum of 3 quarters · filed 2022-05-10 | |
| 2020-12-31 | -$381.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | -$301.00K derived: sum of 2 quarters · filed 2022-03-24 | $1.99M 10-K · filed 2022-03-24 | |
| 2020-09-30 | $80.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $2.37M 10-Q · filed 2021-11-10 | ||
| 2020-06-30 | $2.29M 10-Q · filed 2021-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |